{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:33Z","timestamp":1787698293647,"version":"build-2784847793"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.molmed.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T16:49:36Z","timestamp":1355935776000},"page":"51-60","source":"Crossref","is-referenced-by-count":178,"title":["mTOR: on target for novel therapeutic strategies in the nervous system"],"prefix":"10.1016","volume":"19","author":[{"given":"Kenneth","family":"Maiese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao Zhong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Chen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2012.11.001_bib0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/oxim.3.6.14787","article-title":"Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders","volume":"3","author":"Chong","year":"2010","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.molmed.2012.11.001_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin\u2013receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.11.001_bib0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.11.001_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2012.08.001","article-title":"Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin","volume":"99","author":"Chong","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2443.2000.00365.x","article-title":"Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro","volume":"5","author":"Takahashi","year":"2000","journal-title":"Genes Cells"},{"key":"10.1016\/j.molmed.2012.11.001_bib0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2012.11.001_bib0035","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/MCB.01665-08","article-title":"Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth","volume":"29","author":"Acosta-Jaquez","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0040","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","article-title":"Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0045","doi-asserted-by":"crossref","first-page":"17657","DOI":"10.1074\/jbc.M201142200","article-title":"Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load","volume":"277","author":"Reynolds","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0050","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1074\/jbc.M109.096222","article-title":"mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action","volume":"285","author":"Soliman","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0055","doi-asserted-by":"crossref","first-page":"14693","DOI":"10.1074\/jbc.C109.002907","article-title":"Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellsig.2011.08.010","article-title":"Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k\/Akt signaling pathway","volume":"24","author":"Wang","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2012.11.001_bib0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.200210141","article-title":"LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway","volume":"161","author":"Chen","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0070","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1097-2765(03)00114-X","article-title":"G\u03b2L, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR","volume":"11","author":"Kim","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC\u03b1, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molcel.2011.08.029","article-title":"DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(\u03b2TrCP) E3 ubiquitin ligase and regulates survival and autophagy","volume":"44","author":"Zhao","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0090","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor\u2013mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.11.001_bib0095","doi-asserted-by":"crossref","first-page":"40386","DOI":"10.1074\/jbc.M111.282590","article-title":"The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20102103","article-title":"Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney","volume":"436","author":"Pearce","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2012.11.001_bib0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1101\/gad.12.4.502","article-title":"4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway","volume":"12","author":"Gingras","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2012.11.001_bib0110","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.C500363200","article-title":"Glutamatergic regulation of the p70S6 kinase in primary mouse neurons","volume":"280","author":"Lenz","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1126\/science.1124147","article-title":"Hypothalamic mTOR signaling regulates food intake","volume":"312","author":"Cota","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.11.001_bib0120","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0125","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways","volume":"71","author":"Gulhati","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0130","doi-asserted-by":"crossref","first-page":"23708","DOI":"10.1074\/jbc.M703771200","article-title":"P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration","volume":"282","author":"Hernandez-Negrete","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.200507119","article-title":"Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning","volume":"173","author":"Cai","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0140","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1\u2013TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2\u2013mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"DeYoung","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2012.11.001_bib0155","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/MCB.24.15.6710-6718.2004","article-title":"mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells","volume":"24","author":"Murakami","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0160","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1128\/MCB.24.21.9508-9516.2004","article-title":"Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development","volume":"24","author":"Gangloff","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0165","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1073\/pnas.0901854106","article-title":"mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells","volume":"106","author":"Zhou","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.11.001_bib0170","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2010-07-294801","article-title":"Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7\u03b1 overexpression","volume":"117","author":"Iriuchishima","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2012.11.001_bib0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/cell.2010.0011","article-title":"mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells","volume":"12","author":"Easley","year":"2010","journal-title":"Cell. Reprogramm."},{"key":"10.1016\/j.molmed.2012.11.001_bib0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mcn.2008.06.003","article-title":"Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin","volume":"39","author":"Han","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0185","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1523\/JNEUROSCI.4011-10.2011","article-title":"RTP801\/REDD1 regulates the timing of cortical neurogenesis and neuron migration","volume":"31","author":"Malagelada","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","article-title":"Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions","volume":"9","author":"Magri","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","article-title":"New avenues of exploration for erythropoietin","volume":"293","author":"Maiese","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2012.11.001_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/156720211798120990","article-title":"Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia","volume":"8","author":"Shang","year":"2011","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jcb.23347","article-title":"Erythropoietin mediated bone formation is regulated by mTOR signaling","volume":"113","author":"Kim","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0210","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1600-6143.2006.01433.x","article-title":"mTOR inhibition induces endothelial progenitor cell death","volume":"6","author":"Miriuka","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.molmed.2012.11.001_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2009.12.067","article-title":"Regulation of neural stem\/progenitor cell maintenance by PI3K and mTOR","volume":"470","author":"Sato","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2012.11.001_bib0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2008.01.004","article-title":"The Wnt signaling pathway: aging gracefully as a protectionist?","volume":"118","author":"Maiese","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2012.11.001_bib0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0230","first-page":"3519","article-title":"Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice","volume":"119","author":"Huang","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2012.11.001_bib0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2005.02.004","article-title":"Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease","volume":"75","author":"Chong","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0031-1275289","article-title":"Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients","volume":"119","author":"Zengi","year":"2011","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.molmed.2012.11.001_bib0245","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbamcr.2011.01.029","article-title":"Mitochondrial longevity pathways","volume":"1813","author":"Vendelbo","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2012.11.001_bib0250","first-page":"1","article-title":"Dietary nicotinic acid supplementation improves hepatic zinc uptake and offers hepatoprotection against oxidative damage","volume":"25","author":"Tupe","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.molmed.2012.11.001_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exger.2010.01.004","article-title":"Oxidative stress: biomarkers and novel therapeutic pathways","volume":"45","author":"Maiese","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0565","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14728222.2012.719499","article-title":"Targeting disease through novel pathways of apoptosis and autophagy","volume":"16","author":"Maiese","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.molmed.2012.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","article-title":"Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease","volume":"173","author":"Louneva","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0275","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1471-4159.2004.02956.x","article-title":"Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells","volume":"92","author":"Canu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0280","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4161\/auto.6.6.12573","article-title":"Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia","volume":"6","author":"Qin","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2012.11.001_bib0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/NEN.0b013e31821352bd","article-title":"Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: a widely used inhibitor of autophagy","volume":"70","author":"Wang","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jvs.2009.03.042","article-title":"Autophagy-mediated stress response in motor neuron after transient ischemia in rabbits","volume":"50","author":"Baba","year":"2009","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.molmed.2012.11.001_bib0295","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0300","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.11.001_bib0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neures.2012.03.005","article-title":"Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity","volume":"73","author":"Jeong","year":"2012","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0310","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/labinvest.2010.36","article-title":"Hydrogen peroxide inhibits mTOR signaling by activation of AMPK\u03b1 leading to apoptosis of neuronal cells","volume":"90","author":"Chen","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molmed.2012.11.001_bib0315","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1074\/jbc.M312397200","article-title":"Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18632\/aging.100440","article-title":"Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K\/mTOR pathway, Bad, and Bcl-xL","volume":"4","author":"Shang","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2012.11.001_bib0325","first-page":"263","article-title":"The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3\u03b2 and nuclear factor-\u03baB to foster endogenous microglial cell protection","volume":"19","author":"Chong","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.molmed.2012.11.001_bib0330","doi-asserted-by":"crossref","first-page":"22067","DOI":"10.1074\/jbc.M109.033100","article-title":"mTOR\/S6 kinase pathway contributes to astrocyte survival during ischemia","volume":"284","author":"Pastor","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0335","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1471-4159.2009.06463.x","article-title":"A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death","volume":"112","author":"Choi","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0340","doi-asserted-by":"crossref","first-page":"e45456","DOI":"10.1371\/journal.pone.0045456","article-title":"PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.11.001_bib0345","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2010.02.002","article-title":"Phosphorylation of PRAS40 on Thr246 by PKB\/AKT facilitates efficient phosphorylation of Ser183 by mTORC1","volume":"22","author":"Nascimento","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molmed.2012.11.001_bib0350","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1073\/pnas.1005114107","article-title":"Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells","volume":"107","author":"Carayol","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.11.001_bib0355","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/cdd.2009.121","article-title":"Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL","volume":"17","author":"Luo","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2012.11.001_bib0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/156720212800410858","article-title":"WISP1 (CCN4) autoregulates its expression and nuclear trafficking of beta-catenin during oxidant stress with limited effects upon neuronal autophagy","volume":"9","author":"Wang","year":"2012","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0365","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1002\/cncr.25426","article-title":"Dasatinib induces autophagic cell death in human ovarian cancer","volume":"116","author":"Le","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.molmed.2012.11.001_bib0370","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","article-title":"AMP-activated protein kinase: a potential player in Alzheimer's disease","volume":"118","author":"Salminen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0375","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nature09076","article-title":"Termination of autophagy and reformation of lysosomes regulated by mTOR","volume":"465","author":"Yu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.11.001_bib0380","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1073\/pnas.1013800108","article-title":"Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation","volume":"108","author":"Rong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.11.001_bib0385","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.E08-12-1249","article-title":"ULK\u2013Atg13\u2013FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2012.11.001_bib0390","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4161\/auto.5.7.9296","article-title":"Atg101, a novel mammalian autophagy protein interacting with Atg13","volume":"5","author":"Hosokawa","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2012.11.001_bib0395","doi-asserted-by":"crossref","first-page":"e6007","DOI":"10.1371\/journal.pone.0006007","article-title":"BDNF activates mTOR to regulate GluR1 expression required for memory formation","volume":"4","author":"Slipczuk","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.11.001_bib0400","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","article-title":"Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology","volume":"93","author":"Griffin","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0405","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease","volume":"163","author":"An","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000095562","article-title":"Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease","volume":"22","author":"Paccalin","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.molmed.2012.11.001_bib0415","doi-asserted-by":"crossref","first-page":"e12845","DOI":"10.1371\/journal.pone.0012845","article-title":"Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.11.001_bib0420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by A\u03b2 exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease","volume":"94","author":"Lafay-Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2007.06.075","article-title":"RB1CC1 insufficiency causes neuronal atrophy through mTOR signaling alteration and involved in the pathology of Alzheimer's diseases","volume":"1168","author":"Chano","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0430","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/emboj.2008.163","article-title":"Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila","volume":"27","author":"Imai","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2012.11.001_bib0435","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nn.2372","article-title":"Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss","volume":"12","author":"Tain","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0440","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.3292-06.2006","article-title":"RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation","volume":"26","author":"Malagelada","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0445","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.11.001_bib0450","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson's disease prevents l-DOPA-induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2012.11.001_bib0455","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.11.001_bib0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2012.11.001_bib0465","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4161\/auto.4898","article-title":"Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages","volume":"3","author":"Floto","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2012.11.001_bib0470","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1471-4159.2011.07435.x","article-title":"Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model","volume":"119","author":"Roscic","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0475","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-5-26","article-title":"The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"5","author":"Fox","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.molmed.2012.11.001_bib0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexcr.2011.08.020","article-title":"GADD34 mediates cytoprotective autophagy in mutant huntingtin expressing cells via the mTOR pathway","volume":"318","author":"Hyrskyluoto","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2012.11.001_bib0485","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2012.11.001_bib0490","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/DAD.0b013e3181882c09","article-title":"Fibroblasts from normal skin of a tuberous sclerosis patient show upregulation of mTOR pathway","volume":"31","author":"Jozwiak","year":"2009","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0495","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","article-title":"Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis","volume":"96","author":"Waltereit","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0500","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0505","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0510","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2012.11.001_bib0515","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11207730-000000000-00000","article-title":"Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"14","author":"Curran","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.molmed.2012.11.001_bib0520","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2012.11.001_bib0525","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.11.001_bib0530","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1210\/jc.2009-0662","article-title":"Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer","volume":"94","author":"Jin","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2012.11.001_bib0535","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/carcin\/bgs203","article-title":"Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA","volume":"33","author":"Gulhati","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.molmed.2012.11.001_bib0540","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1673-8527(08)60124-1","article-title":"Efficacy of combined inhibition of mTOR and ERK\/MAPK pathways in treating a tuberous sclerosis complex cell model","volume":"36","author":"Mi","year":"2009","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.molmed.2012.11.001_bib0545","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-7-48","article-title":"NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity","volume":"7","author":"Fokas","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.molmed.2012.11.001_bib0550","first-page":"299","article-title":"Targeting the PI3K\/AKT\/mTOR signaling axis in children with hematologic malignancies","volume":"14","author":"Barrett","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.molmed.2012.11.001_bib0555","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4155\/fmc.12.14","article-title":"mTOR kinase inhibitors as a treatment strategy in hematological malignancies","volume":"4","author":"Grzybowska-Izydorczyk","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.molmed.2012.11.001_bib0560","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412002092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412002092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:20:29Z","timestamp":1539994829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491412002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1471491412002092"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2012.11.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}